Here are relevant reports on : nicotine-replacement-therapy-market
-
Cardiac Rhythm Management Market by Product (Implantable, External Pacemakers, Defibrillators, Cardiac resynchronization therapy (CRT) devices), by End-Users (Hospitals, Home, Ambulatory) Forecasts To 2020
The incidence of cardiovascular diseases (CVD) is increasing with the aging population, changing lifestyle, and increasing stress. It is estimated that 17 million people die of CVD every year. Sudden cardiac arrest (SCA) is the leading cause of death among U.S. adults aged 40 years and above. According to Centre for Disease Control and Prevention (CDC), approximately 250,000 people die every year in the U.S. from SCA.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
The global biologics safety testing market growth is primed to transition from USD 4.2 billion in 2024 to USD 7.2 billion by 2029, showcasing a strong CAGR of 11.1%. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Hyperbaric Oxygen Therapy Equipment Market by Product (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User - Global Forecast to 2022
The global hyperbaric oxygen therapy equipment market is expected to reach $3.21 Billion by 2022 from $2.26 Billion in 2017, growing at a CAGR of 7.1% from 2017 to 2022. Rising incidence and prevalence of acute and chronic wounds, ready availability of hyperbaric oxygen therapy systems, and growing popularity of leisure and adventure activities are some of the major driving factors driving the growth of the global hyperbaric oxygen therapy equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
CAR-t Cells Therapy Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
CAR-t Cells Therapy Market
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028
The global digital therapeutics market, valued at US$4.4B in 2022, is forecasted to grow at a 29.1% CAGR, reaching US$6.1B by 2023 and US$21.9B by 2028. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
CAR T-cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target Antigen (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), End User & Region - Global Forecast to 2029
The global CAR T-cell Therapy market, valued at US$37.4B in 2023, is forecasted to grow at a 39.6% CAGR, reaching US$5.5B by 2024 and US$29.0B by 2029. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy. The growing prevalence of cancer is also expected to support lucrative market growth.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021
The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) & Region - Global Forecast to 2027
The global nerve repair market growth is primed to transition from $6.5 billion in 2022 to $11.6 billion by 2027, showcasing a strong CAGR of 12.1%. This growth is driven by the increasing prevalence of neurological disorders, rising geriatric population, high incidence of nerve injuries, and government support for neurological research.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2028
The global home healthcare market, valued at US$230.0B in 2022, is forecasted to grow at a 8.9% CAGR, reaching US$250B by 2023 and US$383B by 2028. The rising demand for cost-effective healthcare delivery due to the increasing healthcare costs and the increase in the geriatric population are the major factors driving the market’s growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
